Rehan Aziz, MD.
Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School.
Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
There are no approved pharmacotherapies for stimulant use disorders. Lots of medications have been studied and the results have been mixed. Here we provide you with the latest data, and some treatment recommendations.
Anthony Charuvastra, MDDr. Charuvastra has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The MTA was a classic research effort aimed at reaching more definitive conclusions about the relative effectiveness of stimulant medications and behavioral treatments for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). The results have proven enduring and inspiring, leading to the development of new and innovative treatment approaches.
Psychiatrist Shawn Christopher Shea shares his top tips on engaging patients in their medication treatment. Dr. Shea has been fine tuning the art of doctor-patient communications for over 30 years through best-selling texts on psychiatric interviewing and suicide assessment. His latest book, The Medication Interest Model, presents a unique model for talking...